Ligand validation:3TYK

HY0: HYGROMYCIN B VARIANT

HY0 is a Ligand Of Interest in 3TYK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3TYK_HY0_A_342	94%	38%	0.074	0.972	0.93	1.5	2	7	0	0	100%	1
3W0O_HY0_A_402	92%	27%	0.088	0.979	1.55	1.41	6	7	0	0	100%	1
3W0N_HY0_A_402	89%	29%	0.091	0.971	1.16	1.65	2	7	0	0	100%	1
3W0R_HY0_A_402	88%	35%	0.101	0.976	1.13	1.42	4	7	0	0	100%	1
3W0S_HY0_A_401	86%	43%	0.105	0.975	0.95	1.25	1	5	0	0	100%	1
3W0Q_HY0_A_402	85%	43%	0.108	0.974	0.85	1.34	1	6	0	0	100%	1
4XCB_HY0_B_303	87%	37%	0.087	0.958	1.37	1.09	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.